AXA’s Linden Thomson: You need a scientific background to be a biotech investor

Loading player...

Linden Thomson, manager of the Axa Framlington Biotech fund, speaks about the 'heavily momentum driven' biotech sector, and why Biden’s inflation reduction act could tighten R&D investment.

1 Mar 2023 English United Kingdom Business · Investing

Other recent episodes

What can wealth managers can do about modern slavery?

Dr Martin Buttle and Dame Sara Thornton discuss the key findings of CCLA's inaugural Global Modern Slavery Benchmark and how the industry can use it for better engagement.

11 Aug 16 min

JM Finn's Jon Cunliffe: This is the biggest risk of H2 2025

Jon Cunliffe, head of investments at JM Finn, discusses how the firm is positioning for the second half of the year.

4 Aug 16 min

Jupiter’s Alex Savvides: ‘It was obvious to everyone there would be outflows’

Nine months into managing the UK Dynamic Equity Fund, Alex Savvides discusses takeover challenges, strategic bids, and where he sees new opportunities.

9 Jul 29 min

IIMI CEO: These are the biggest challenges boutiques face

Dani Hristova, CEO of the Independent Investment Management Initiative (IIMI), explains how recent FCA proposals could change the game for boutique firms.

27 May 17 min

Nick Train: The two things my funds need to bounce back

Nick Train discusses buying big into Rightmove, recent ‘pain’ for consumer sector holdings, and how his £1.4bn Finsbury Growth & Income investment trust can return to outperformance.

21 May 19 min

All episodes